PT3774745T - Cristal de composto de oxazol - Google Patents

Cristal de composto de oxazol

Info

Publication number
PT3774745T
PT3774745T PT197184658T PT19718465T PT3774745T PT 3774745 T PT3774745 T PT 3774745T PT 197184658 T PT197184658 T PT 197184658T PT 19718465 T PT19718465 T PT 19718465T PT 3774745 T PT3774745 T PT 3774745T
Authority
PT
Portugal
Prior art keywords
compound crystal
oxazole compound
oxazole
crystal
compound
Prior art date
Application number
PT197184658T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of PT3774745T publication Critical patent/PT3774745T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/4211,3-Oxazoles, e.g. pemoline, trimethadione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT197184658T 2018-04-04 2019-04-03 Cristal de composto de oxazol PT3774745T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018072717 2018-04-04

Publications (1)

Publication Number Publication Date
PT3774745T true PT3774745T (pt) 2024-06-25

Family

ID=66223774

Family Applications (1)

Application Number Title Priority Date Filing Date
PT197184658T PT3774745T (pt) 2018-04-04 2019-04-03 Cristal de composto de oxazol

Country Status (26)

Country Link
US (4) US11414391B2 (enExample)
EP (2) EP4400167A3 (enExample)
JP (4) JP7326295B2 (enExample)
KR (2) KR102764726B1 (enExample)
CN (1) CN111902402A (enExample)
AU (2) AU2019249562B2 (enExample)
BR (1) BR112020019377A2 (enExample)
CA (1) CA3095866A1 (enExample)
DK (1) DK3774745T3 (enExample)
EA (1) EA202092393A1 (enExample)
ES (1) ES2982586T3 (enExample)
FI (1) FI3774745T3 (enExample)
HR (1) HRP20240858T1 (enExample)
HU (1) HUE066793T2 (enExample)
IL (2) IL277730B2 (enExample)
LT (1) LT3774745T (enExample)
MX (1) MX2020010435A (enExample)
MY (1) MY202406A (enExample)
PH (1) PH12020551605A1 (enExample)
PL (1) PL3774745T3 (enExample)
PT (1) PT3774745T (enExample)
SG (1) SG11202009564TA (enExample)
SI (1) SI3774745T1 (enExample)
TW (2) TWI860993B (enExample)
WO (1) WO2019194211A1 (enExample)
ZA (1) ZA202006134B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3774745T3 (da) * 2018-04-04 2024-06-17 Otsuka Pharma Co Ltd Krystal af en oxazolforbindelse
EP4501324A1 (en) 2022-03-25 2025-02-05 Otsuka Pharmaceutical Co., Ltd. Wound treatment composition
CN115887463A (zh) * 2022-12-27 2023-04-04 瑞石生物医药有限公司 一种含环酰胺化合物的药物组合物
GB202306663D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Combination therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI330639B (en) * 2005-11-15 2010-09-21 Otsuka Pharma Co Ltd Oxazole compound and pharmaceutical composition
WO2014034958A1 (en) * 2012-08-30 2014-03-06 Otsuka Pharmaceutical Co., Ltd. Method for producing oxazole compound
TWI726027B (zh) 2015-12-28 2021-05-01 日商大塚製藥股份有限公司 軟膏
DK3774745T3 (da) * 2018-04-04 2024-06-17 Otsuka Pharma Co Ltd Krystal af en oxazolforbindelse

Also Published As

Publication number Publication date
KR20250022254A (ko) 2025-02-14
US11414391B2 (en) 2022-08-16
EP3774745B1 (en) 2024-05-29
BR112020019377A2 (pt) 2021-01-05
DK3774745T3 (da) 2024-06-17
US20210147370A1 (en) 2021-05-20
MY202406A (en) 2024-04-27
CN111902402A (zh) 2020-11-06
ES2982586T3 (es) 2024-10-16
TWI860993B (zh) 2024-11-11
EP3774745A1 (en) 2021-02-17
AU2024220015A1 (en) 2024-10-17
JP7326295B2 (ja) 2023-08-15
CA3095866A1 (en) 2019-10-10
WO2019194211A1 (en) 2019-10-10
US20220411386A1 (en) 2022-12-29
TW202515853A (zh) 2025-04-16
ZA202006134B (en) 2023-03-29
TW202012380A (zh) 2020-04-01
HUE066793T2 (hu) 2024-09-28
KR20200139736A (ko) 2020-12-14
MX2020010435A (es) 2020-10-28
SI3774745T1 (sl) 2024-08-30
EP4400167A3 (en) 2024-09-25
FI3774745T3 (fi) 2024-06-19
JP2025128238A (ja) 2025-09-02
IL277730B2 (en) 2025-02-01
PL3774745T3 (pl) 2024-08-19
SG11202009564TA (en) 2020-10-29
US20250250243A1 (en) 2025-08-07
JP2021517111A (ja) 2021-07-15
IL277730A (en) 2020-11-30
EP4400167A2 (en) 2024-07-17
IL277730B1 (en) 2024-10-01
LT3774745T (lt) 2024-07-10
AU2019249562B2 (en) 2024-06-27
JP2022037040A (ja) 2022-03-08
HRP20240858T1 (hr) 2024-10-11
PH12020551605A1 (en) 2021-04-26
KR102764726B1 (ko) 2025-02-11
IL315425A (en) 2024-11-01
US11840512B2 (en) 2023-12-12
AU2019249562A1 (en) 2020-10-22
EA202092393A1 (ru) 2021-01-25
JP2024001115A (ja) 2024-01-09
US20240076275A1 (en) 2024-03-07

Similar Documents

Publication Publication Date Title
DK3810581T3 (da) Krystalmodifikationer af odevixibat
IL283333A (en) New heterocyclic compounds
LT3810602T (lt) Junginiai
EP3392248A4 (en) 2- (3-E-THANSULFONYLPYRIDIN-2-YL) -5- (trifluoromethanesulfonyl) benzoxazole-CRYSTAL
EP3736945A4 (en) ENGINE
EP3976603C0 (en) HERBICIDAL COMPOUNDS
PT3774745T (pt) Cristal de composto de oxazol
AR120804A1 (es) Derivados de isoxazolina
HUE059337T2 (hu) Herbicid hatású vegyületek
IL279620B1 (en) Compounds
EP3737667C0 (en) HERBICIDAL COMPOUNDS
EP4058438C0 (en) HERBICIDAL COMPOUNDS
EP3876397A4 (en) ENGINE
DK3530890T3 (da) Drev med integreret ORC
DK3818047T3 (da) Hidtil ukendte forbindelser til bekæmpelse af arthropoder
DK3782986T3 (da) Heterocyklisk forbindelse
EP3872968A4 (en) ENGINE
DK3801546T3 (da) Indolforbindelse til behandling af interstitiel cystitis
HUE053924T2 (hu) Kompozíció cukorbetegség kezelésére
EP4080908A4 (en) PIEZOELECTRICAL FILM
EP3476835A4 (en) CRYSTAL OF A CHINOLINID DERIVATIVE
EP3893367A4 (en) ENGINE
EP3852238A4 (en) ENGINE
EP3852248A4 (en) ENGINE
EP3832163A4 (en) CLAMPING DEVICE